ArticleNucleic acids research2026
SNPnexus: an enhanced web platform for large-scale and multi-sample variant analysis (2025 update).
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
SNPnexus is a long-standing web-based platform for the functional annotation and prioritization of genetic variants. Since its previous release, SNPnexus has undergone substantial backend re-engineering resulting in major performance improvements and a complete restructuring of the underlying datasets. A redesigned interface now enables larger queries and multi-sample analysis enabling comparative workflows such as identifying shared pathogenic variants in disease cohorts and divergent mutations in cancer evolution studies. SNPnexus increased its capacity to 150 000 variants per query and introduced pre-annotation filters that allow users to restrict analyses to selected genes or genomic regions, improving efficiency while enabling targeted interrogation of high-priority targets. SNPnexus integrates updated and expanded annotations across both GRCh37 and GRCh38, covering genomic consequences, in silico pathogenicity predictions, population allele frequencies, evolutionary conservation, regulatory elements, biological pathways, and clinical associations. The refreshed result interface provides interactive visualizations for single-sample and cohort-level outputs, together with advanced filtering and export options. Optional user accounts now support query history and real-time job monitoring while preserving full, unregistered access for all users. SNPnexus remains free and open to all users without login requirements at https://snpnexus.org/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.